IN2014MU01196A - - Google Patents
Info
- Publication number
- IN2014MU01196A IN2014MU01196A IN1196MU2014A IN2014MU01196A IN 2014MU01196 A IN2014MU01196 A IN 2014MU01196A IN 1196MU2014 A IN1196MU2014 A IN 1196MU2014A IN 2014MU01196 A IN2014MU01196 A IN 2014MU01196A
- Authority
- IN
- India
- Prior art keywords
- compound
- formula
- preparation
- disclosed
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1196MU2014 IN2014MU01196A (enrdf_load_html_response) | 2014-03-29 | 2014-12-25 | |
| PCT/IB2014/067330 WO2015150890A1 (en) | 2014-03-29 | 2014-12-25 | A process for preparation of trans-sulfuric acid mono-{2-(5-(3-amino-propyl)-[1,3,4]oxadiazol-2-yl]-7-oxo-1,6-diazabicyclo [3.2.1] oct-6-yl}ester |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1196MU2014 IN2014MU01196A (enrdf_load_html_response) | 2014-03-29 | 2014-12-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU01196A true IN2014MU01196A (enrdf_load_html_response) | 2015-10-02 |
Family
ID=54239456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1196MU2014 IN2014MU01196A (enrdf_load_html_response) | 2014-03-29 | 2014-12-25 |
Country Status (2)
| Country | Link |
|---|---|
| IN (1) | IN2014MU01196A (enrdf_load_html_response) |
| WO (1) | WO2015150890A1 (enrdf_load_html_response) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7273420B2 (ja) | 2018-01-25 | 2023-05-15 | エボポイント、バイオサイエンシズ、カンパニー、リミテッド | β－ラクタマーゼ阻害剤及びその用途 |
| WO2023088375A1 (zh) | 2021-11-17 | 2023-05-25 | 苏州信诺维医药科技股份有限公司 | β-内酰胺酶抑制剂中间体及制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2231667B1 (en) * | 2008-01-18 | 2013-09-04 | Merck Sharp & Dohme Corp. | Beta-lactamase inhibitors |
| BR112013032974A2 (pt) * | 2011-08-30 | 2016-09-06 | Wockhardt Ltd | "derivados de 1,6-diazabiciclo [3,2,1]-octan-7-ona, seus usos, e composições farmacêuticas". |
| CA2868553A1 (en) * | 2012-03-30 | 2013-10-03 | Cubist Pharmaceuticals, Inc. | 1,3,4-oxadiazole and 1,3,4-thiadiazole .beta.-lactamase inhibitors |
-
2014
- 2014-12-25 WO PCT/IB2014/067330 patent/WO2015150890A1/en active Application Filing
- 2014-12-25 IN IN1196MU2014 patent/IN2014MU01196A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015150890A1 (en) | 2015-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020001278A (es) | Sintesis de compuestos de carbamoilpiridona policiclica. | |
| NZ726356A (en) | Processes for preparing antiviral compounds | |
| GR20140100479A (el) | Συνθεση λιραγλουτιδης | |
| AU2016277367A8 (en) | Aryl sulfonohydrazides | |
| IN2014CH00247A (enrdf_load_html_response) | ||
| MX369501B (es) | Proceso para la preparación de 5-fluoro-1h-pirazoles partiendo de hexafluoropropeno. | |
| MX2016010973A (es) | Compuestos de aminocarbonilcarbamato. | |
| MA39843A (fr) | Pyridine-2-amides utiles comme agonistes de cb2 | |
| TW201613871A (en) | Process for the preparation of 5-fluoro-1H-pyrazoles starting from hexafluoropropene | |
| PH12018550165A1 (en) | An improved process for the preparation of butorphanol tartrate | |
| MX2015013589A (es) | Proceso e intermediario para la preparacion de pregabalina. | |
| IN2014MU01192A (enrdf_load_html_response) | ||
| IN2014MU00195A (enrdf_load_html_response) | ||
| MX2019004024A (es) | Metodo para preparar acetofenonas sustituidas con ciclopropilo. | |
| MX382659B (es) | Proceso para la preparación de derivados de tiazol. | |
| MX2016015623A (es) | Proceso para la preparacion de derivados dihidroisoxazol. | |
| IN2014MU00194A (enrdf_load_html_response) | ||
| IN2014MU01196A (enrdf_load_html_response) | ||
| MX2017002609A (es) | Procedimiento mejorado para la preparacion de lacosamida y su intermediario novedoso. | |
| IN2014CH00444A (enrdf_load_html_response) | ||
| IN2014MU00858A (enrdf_load_html_response) | ||
| IN2014MU01195A (enrdf_load_html_response) | ||
| CL2016002925A1 (es) | Procedimiento mejorado para preparar ácidos crotónicos sustituidos | |
| IN2014MU00072A (enrdf_load_html_response) | ||
| IN2015CH00214A (enrdf_load_html_response) |